Valery E Lemmens
Overview
Explore the profile of Valery E Lemmens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
815
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lurvink R, Rijken A, Bakkers C, Lemmens V, de Reuver P, Tuynman J, et al.
Surg Endosc
. 2022 Jan;
36(9):6551-6557.
PMID: 35059835
Background: This study aimed to assess the impact of open or laparoscopic resection of primary colorectal cancer (CRC) on the development of metachronous colorectal peritoneal metastases (CPM) in a population-based...
2.
van Nassau S, Bond M, Scheerman I, van Breeschoten J, Kessels R, Valkenburg-van Iersel L, et al.
JAMA Netw Open
. 2021 Sep;
4(9):e2124766.
PMID: 34505885
Importance: Triplet chemotherapy with fluorouracil, folinic acid, oxaliplatin, and irinotecan plus bevacizumab (FOLFOXIRI-B) is an effective first-line treatment option for patients with metastatic colorectal cancer (mCRC). However, the degree of...
3.
Rijken A, Bakkers C, van Erning F, van der Geest L, de Vos-Geelen J, Besselink M, et al.
Pancreas
. 2021 Aug;
50(6):827-833.
PMID: 34347730
Objective: The aim of the study was to gain insight in the incidence, treatment, and survival of patients with synchronous pancreatic peritoneal metastases. Methods: All patients diagnosed with pancreatic cancer...
4.
Hugen N, Kanne H, Simmer F, van de Water C, Voorham Q, Ho V, et al.
Int J Cancer
. 2021 May;
149(6):1266-1273.
PMID: 33990961
Umbilical metastases form a clinical challenge, especially when they represent the first sign of malignant disease and the primary tumor is unknown. Our study aims to generate insight into the...
5.
Mackay T, van Erning F, van der Geest L, de Groot J, Haj Mohammad N, Lemmens V, et al.
Eur J Cancer
. 2018 Nov;
106:99-105.
PMID: 30476732
Introduction: The relation between the primary origin of metastasised pancreatic ductal adenocarcinoma (PDAC)-head, body or tail-metastatic patterns and outcomes has not yet been investigated in large population-based studies. Methods: Patients...
6.
van Erning F, Mackay T, van der Geest L, Koerkamp B, van Laarhoven H, Bonsing B, et al.
Acta Oncol
. 2018 Sep;
57(12):1655-1662.
PMID: 30264642
Background: The association between pancreatic ductal adenocarcinoma (PDAC) location (head, body, tail) and tumor stage, treatment and overall survival (OS) is unclear. Methods: Patients with PDAC diagnosed between 2005 and...
7.
Toes-Zoutendijk E, Kooyker A, Elferink M, Spaander M, Dekker E, de Koning H, et al.
Gut
. 2017 Oct;
67(9):1745-1746.
PMID: 29055907
No abstract available.
8.
Rovers K, Simkens G, Vissers P, Lemmens V, Verwaal V, Bremers A, et al.
Eur J Cancer
. 2017 Feb;
75:132-140.
PMID: 28222307
Background: In the Netherlands, surgery for peritoneal metastases of colorectal cancer (PMCRC) is centralised, whereas PMCRC is diagnosed in all hospitals. This study assessed whether hospital of diagnosis affects treatment...
9.
Simkens G, Verwaal V, Lemmens V, Rutten H, de Hingh I
Medicine (Baltimore)
. 2016 Oct;
95(41):e5111.
PMID: 27741129
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is an extensive procedure with considerable morbidity. Since only few hospitals perform CRS + HIPEC, this might lead to confounded outcomes between...
10.
Bakens M, van der Geest L, van Putten M, van Laarhoven H, Creemers G, Besselink M, et al.
Cancer Med
. 2016 Sep;
5(10):2825-2831.
PMID: 27671746
Adjuvant chemotherapy after pancreatoduodenectomy for pancreatic cancer is currently considered standard of care. In this nationwide study, we investigated which characteristics determine the likelihood of receiving adjuvant chemotherapy and its...